S H Kelkar and Company DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.61×0.62×0.63×0.68×0.60×
1.12×0.92×0.57×0.84×0.76×
5.3%5.2%9.5%11.3%8.1%
0.85×0.85×0.83×0.83×0.75×
2.14×2.14×2.11×1.98×2.02×
6.6%5.3%6.0%10.5%5.6%
5.3%5.3%5.9%10.8%5.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SHK₹125.00

S H Kelkar and Company Limited

· Chemicals
₹ CrorePeersATULANURASBAYERCROPCAMLINFINESWANCORPCLEANDEEPAKNTRTIRUMALCHMMcap ₹1,730 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.600.680.630.620.61
Interest Burden (Pretax/EBIT) ×0.760.840.570.921.12
EBIT Margin %8.1211.279.535.175.28
Asset Turnover ×0.750.830.830.850.85
Financial Leverage (Assets/Equity) ×2.021.982.112.142.14
ROE (5-step product, year-end total equity) %5.6410.516.025.316.60
ROE (owners' profit / average owners' equity) %5.8910.755.905.265.26
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.